Air Liquide : Home Healthcare Acquisitions in Poland
PARIS -- July 10, 2013
Regulatory News :
Poland is one of the largest countries in the European Union, with steady
economic growth. It offers development opportunities in industrial and
healthcare markets. In this context, Air Liquide (Paris:AI) is expanding its
home healthcare activity in this country with the acquisition of two
companies: HELP! and Ventamed.
These acquisitions will enable Air Liquide to provide its home healthcare
services nationwide to patients who suffer from chronic respiratory diseases
such as chronic obstructive pulmonary disease, sleep apnea, or conditions
requiring mechanical ventilation.
Founded twenty years ago, HELP! is a specialist in home respiratory healthcare
and the leader of home-based ventilation in Poland, covering most of the
Polish Counties. Ventamed also specializes in home ventilation services. It
covers the western part of the country.
Together, the two companies have around 20 employees.
With these two acquisitions, Air Liquide becomes one of the key players in the
home healthcare market in Poland.
Pascal Vinet, Vice President, Healthcare Global Operations and member of the
AirLiquide Group Executive Committee, commented: “Since 2005, Air Liquide has
been developing its home healthcare activity in Poland, with services for
patients suffering from sleep apnea or requiring long-term oxygen therapy. We
will now benefit from the expertise and commitment of HELP! and Ventamed's
teams. These two acquisitions give us a leadership position in the segment of
home ventilation and reinforce our presence in Eastern Europe.”
Air Liquide in Poland
Founded in 1995, Air Liquide Poland employs more than 300 people. Present in
Poland’s major industrial regions, AirLiquide supplies a number of industries
such as aeronautics, automotive, food & beverages, chemicals, defense,
electronics, energy, metallurgy, mining, metal fabrication and also healthcare
Air Liquide Healthcare
Air Liquide Healthcare supplies medical gases, home healthcare services,
hygiene products, medical equipment and specialty ingredients.
In 2012, it served over 7,500hospitals and 1 millionpatients at home
throughout the world.
The Group’s Healthcare business reached € 2,482million in revenues in 2012,
Air Liquide, European leader and 3^rdworldwide in home healthcare, provides
home healthcare services in compliance with medical prescription for patients
suffering from chronic diseases such as COPD (Chronic Obstructive Pulmonary
Disease), sleep apnea and diabetes. These home healthcare services are being
developed in addition to hospital care, enabling patients to enjoy better
quality of life and local authorities to reduce costs.
Home Healthcare represents 43% of AirLiquide’s total 2012 Healthcare revenue.
Air Liquide is the world leader in gases for industry, health and the
environment, and is present in 80countries with close to 50,000employees.
Oxygen, nitrogen, hydrogen and rare gases have been at the core of Air
Liquide’s activities since its creation in 1902. Using these molecules, Air
Liquide continuously reinvents its business, anticipating the needs of current
and future markets. The Group innovates for the good of society while
delivering profitable growth and consistent performance.
Innovative technologies that curb polluting emissions, lower industry’s energy
use, recover and reuse natural resources or develop the energies of tomorrow,
such as hydrogen, biofuels or photovoltaic energy… Oxygen for hospitals, home
healthcare, fighting nosocomial infections… Air Liquide combines many products
and technologies to develop valuable applications and services not only for
its customers but also for society.
A partner for the long term, Air Liquide relies on employee commitment,
customer trust and shareholder support to pursue its vision of sustainable,
competitive growth. The diversity of Air Liquide’s teams, businesses, markets
and geographic presence provides a solid and sustainable base for its
development and strengthens its ability to push back its own limits, conquer
new territories and build its future.
Air Liquide explores the best that air can offer to preserve life, staying
true to its Corporate Social Responsibility and sustainable development
approach. In 2012, the Group’s revenues amounted to €15.3billion of which
82% were generated outside France. AirLiquide is listed on the Paris Euronext
stock exchange (compartment A) and is a member of the CAC 40 and Dow Jones
Euro Stoxx 50 indexes.
Follow us on Twitter @AirLiquideGroup
Corinne Estrade-Bordry, + 33 (0)1 40 62 51 31
Garance Bertrand, + 33 (0)1 40 62 59 62
Virginia Jeanson, +33 (0) 1 40 62 57 37
Annie Fournier, +33 (0) 1 40 62 57 18
Communication Air Liquide Healthcare
Muriel Doucet, + 33 (0)1 49 69 46 46
Press spacebar to pause and continue. Press esc to stop.